GPN vs LII

GPN presents a stark contrast between strong deterministic health and deteriorating growth. While the Piotroski F-Score of 7/9 indicates robust financial health and the stock trades significantly below its Graham Number ($98.18) and book value (P/B 0.71), these value metrics are countered by a severe collapse in earnings growth (-59.20% YoY) and a bearish technical trend (0/100). The massive discrepancy between the current P/E (15.42) and Forward P/E (4.22) suggests the market is pricing in a recovery that is not yet evident in the quarterly data. Consequently, the stock appears to be a deep-value play with significant execution risk.

LII exhibits significant financial deterioration, highlighted by a weak Piotroski F-Score of 3/9 and a massive valuation gap where the current price ($495.52) trades at a severe premium to both its Graham Number ($130.92) and Intrinsic Value ($159.53). While the company maintains high ROE and profitability, these are offset by negative YoY revenue (-11.20%) and earnings growth (-17.90%). The combination of bearish insider sentiment, a failing technical trend, and poor liquidity (Quick Ratio 0.52) suggests a high risk of price correction.